Mycobacteria Registry Study: Prospective Observational Study in Austria

Last updated: July 22, 2024
Sponsor: Ludwig Boltzmann Institute for Lung Health
Overall Status: Active - Recruiting

Phase

N/A

Condition

Hiv

Lung Disease

Treatment

N/A

Clinical Study ID

NCT06522347
TBC-NTM
  • Ages > 18
  • All Genders

Study Summary

The goal of this non-interventional registry study is to systematically collect epidemiological and clinical data throughout the treatment course to learn about effectiveness of treatments. We will document the natural course of therapy without additional interventions. The main question to answer is:

What are the risk factors for mortality due to infection with Mycobacteria tuberculosis (TB) or Nontuberculous mycobacteria (NTM) in Austria?

Data from participants already receiving treatment as part of their regular medical care for TB or NTM infections will be collected.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • patients diagnosed with Mycobacterium tuberculosis or non-tuberculous mycobacteriainfection

  • individuals aged 18 years or older

  • written informed consent

Exclusion

Exclusion Criteria:

  • to not comprehend and rightfully judge participation

Study Design

Total Participants: 1000
Study Start date:
January 01, 2023
Estimated Completion Date:
December 31, 2053

Connect with a study center

  • Klinik Hietzing

    Vienna, 1130
    Austria

    Active - Recruiting

  • Klinik Penzing

    Vienna, 1140
    Austria

    Active - Recruiting

  • Ludwig Boltzmann Institut for Lung Health

    Vienna, 1140
    Austria

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.